Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Thumbnail

Pacemaker implantations following TAVR may be more common than previously thought

Studies have shown that permanent pacemaker implantation is among the most common complications for patients undergoing transcatheter aortic valve replacement (TAVR). Still, the risk may be underestimated, according to a recent analysis.

FDA expands approval of Impella heart pumps for use in high-risk PCIs

The FDA expanded the approval of Abiomed’s premarket approval for the company’s Impella CP heart pump for use in high risk PCIs.

Breakfast cereal does the heart good

New research reveals the mechanism by which healthy cereals reduce the amount of cholesterol in the blood stream. 

One minute can help patients avoid unnecessary hospitalization

One minute is not a long stretch of time. But according to a new study from the Mayo Clinic, it could be just enough time to save a life and avoid unnecessary hospitalizations.

An aspirin a day keeps the heart attacks away, at least for some

Experts are divided over whether daily aspirin for healthy people is a good thing; the latest study attempts to clarify the confusion. 

Smokers under 50 years old have 8-fold increased risk of acute STEMI

Cigarette smokers who were younger than 50 years old were more than eight times more likely to have an acute ST-segment elevation MI (STEMI) than non-smokers in their age category, according to an analysis of two studies in the United Kingdom.

Studies may underestimate permanent pacemaker implantations following TAVR

An analysis of 28 multicenter registries and nine randomized trials found that transcatheter aortic valve replacement (TAVR) studies tended to underestimate the incidence of permanent pacemaker implantations because they do not include patients who had permanent pacemakers before undergoing TAVR.

TAVR, TAVI market predicted to be worth $5.9 billion by 2022

Hefty growth is expected for the transcatheter aortic valve replacement and implantation (TAVR and TAVI) market, according to a new report that projects the market will be valued at $5.9 billion by 2022.

Displaying 1217 - 1224 of 2712

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.